Upload
kanan
View
46
Download
0
Tags:
Embed Size (px)
DESCRIPTION
GROUP 5 IN VITRO MODELS FOR HUMAN MAST CELLS. Trainer: Ilan Hammel Trainees: Patricia Valentin Mansour Seaf Adi Efergan Iva Polakovicova Rosa Torres. Introduction. Differences between human and mouse mast cells. Limitation of HuMCs - PowerPoint PPT Presentation
Citation preview
GROUP 5
IN VITRO MODELS FOR HUMAN MAST CELLS
Trainer: Ilan Hammel
Trainees: Patricia Valentin Mansour SeafAdi EferganIva PolakovicovaRosa Torres
• Differences between human and mouse mast cells. • Limitation of HuMCs
AIM: To make a comparison between different Human mast cell models
MCs Cell lines- HMC-1 LAD-2
Primary cultured MCs- HLMCs sMCs Peripheral derived CD34+ cells ESMCs CBMCs
Introduction
Introduction
TO BE DISCUSSED:
• Similarities vs differences
• Gene profile and mRNA expression
• Proteins composition and protein levels
• Stage of maturation
• Granule content
• Cell surface receptors expression
• Modes of activation and secretion
Vascular endothelial growth factors synthesized by human lung mast cells exert
angiogenic effects Aikaterini Detoraki, MD, PhD,a Rosaria I. Staiano, PhD,a Francescopaolo Granata, MD, PhD,a Giorgio Giannattasio, MD,a• Nella Prevete, PhD,a Amato de Paulis, MD,a Domenico Ribatti, MD,b Arturo Genovese, MD,a Massimo Triggiani, MD,
• PhD,a and Gianni Marone, MDa
Expression of VEGFs in human mast cells. A. VEGF-A, B, C, D and PlGF RT-PCR amplification products
from HLMCs, LAD-2 cells, and HMC-1 cells. B. Immunoblot with anti–VEGF-B, C, D and anti–GAPDH
antibodies of HLMC, LAD-2, and HMC-1 lysates. MCF-7 and RAW 264.7 cells were used as positive controls.
Human mast cells express and synthesize VEGFs
Effects of PGE2 on VEGF production from human mast cells. A. Expression of VEGF-A, B, C and D was determined in LAD-2 cells by qPCR.B. VEGF-A release was determined in HLMCs by using ELISA.
Effects of NECA on VEGF production from human mast cells. A. Expression of VEGF-A, B, C and D was determined in HMC-1 cells by qPCR. B. VEGF-A release was determined in HLMCs by using ELISA.
LAD-2 HMC-1
HLMCs
PGE2 and NECA affect expression and release of VEGF in a time-dependent manner
HLMCs
Expression of VEGFRs in human mast cells. A. VEGFR-1, soluble VEGFR-1,
VEGFR-2, and GAPDH RT-PCR amplification products from HLMCs, LAD-2 cells, and HMC-1 cells.
B. The cell surface expression of VEGFRs in HLMCs was determined by FACS.
HLMCs
Human mast cells express both VEGFR-1 and VEGFR-2
Human mast cells synthesize and releaseangiogenin, a member of the ribonuclease A
(RNase A) superfamilyMarianna Kulka,*,1 Nobuyuki Fukuishi,† and Dean D. Metcalfe†
Analysis of ANG expression.A. HMC, HMC-1, LAD2, and CD34+- derived HuMC expression of ANG and actin by qRT-PCR.
Human mast cells synthesize angiogenin
Human embryonic stem cells: a source of mast cells for the study of allergic and
inflammatory diseasesMartina Kovarova, Anne M. Latour, Kelly D. Chason, Stephen L. Tilley and Beverly H. Koller
Phenotype of Embryonic Stem cell-derived mast cells.A. Cells were stained with α- tryptase, α-chymase , and Toluidine blue. B. Quantification of tryptase- and chymase- positive cells in culture during mast cell differentiation.C. Enzymatic activity of tryptase measured in mast cell lysates. D. Inhibition of tryptase activity by
tryptase antagonist.
ESMCs produce tryptase and chymase in the same manner as CBMCs
Expression of FcRI and c-Kit on ESMCs.
FACS analysis of ESMCs.A. ESMCs differentiated by co-culture
with OP9. B. ESMCs differentiated by EB formation. C. CBMCs. D. Expression of c-Kit in ESMCs differentiated by EB formation. E. Double staining of ESMCs by α-IgE and α-c-Kit antibody.
ESMCs- OP9
ESMCs- EB
CBMCs
ESMCs and CBMCs express FcεRI and c-Kit on the cell surface
ESMCs CBMCsERK phosphorylation- following FcεRI activation
Intracellular Ca 2+ release- following FcεRI activation
Histamine secretion
TNF-α secretion
PGD2 release
Activation of ESMC by crosslinking of FcεRI
Human mast cells differentiated from genetically modified hES cells.
Mast cells derived from GFP-hES express tryptase. Top panel: GFP-hES cells. Bottom panels: Mast cells derived from non-transfected H1 clone.
ESMCs with the same genetic modification can be generated
Supporting Papers
Skin MCs
LAD-2 HMC-1
FCεRIHistamine secretionTryptaseChymase
*
Mast cell lines HMC-1 and LAD2 in comparison with mature human skin mast cells
* Histamine content OK
Cultured Mast Cells from Patients with Asthma and Controls Respond with Similar Sensitivity to IgE-
Mediated ActivationTable 2 Mast cell numbers obtained from asthmatics and control persons (median and range).
The CD63 MFI and the % CD63+ mast cells cultured from patients with asthma and controls were similar. A. The maximal CD63 MFI B. The median % CD63+ mast
cells measured on allergen-specific activated mast cells from patients with asthma and controls.
Gene Expression Profiles of 16 Samples2 basophil samples,2 eosinophil samples,2 neutrophil samples,3 lung-derived MC samples, 3 tonsil-derived MC sample,3 peripheral blood progenitor-derived MC samples,1 cord blood-derived MC sample
Gene Expression Profiling of Human Mast Cell Subtypes: An In Silico Study
Summary
• What are the biological questions that are best addressed by the model that you discussed?
To analyze the function and development of human mast cells.
Mast cells play a pivotal role in bronchial asthma, allergic diseases and are also implicated in other chronic inflammatory conditions and tumor growth. Therefore, human MCs are the most appropriate model for the investigation of human MCs related disease.
Summary• If more than one model exist- do the distinct models yield similar results? If not, point out the discrepancies. Criticism of the model discussed.
Human mast cells can be derived from isolated CD34+ or CD133+ hematopoietic precursors from either cord blood or peripheral blood – need to be cultured several weeks
Alternatively, mature human mast cells can be isolated from a few human tissues, including lung, skin and gut – can be used immediately
Limitations: 1. Low number of cells2. Cannot be cultured indefinitely- continuous source is required3. Genetic differences are present between each population4. Primary mast cells cannot be easily genetically manipulated5. Long culturing in the same condition affects the fenotype
Suggestions:Differentiating cells by using co-culture on supporting cell types such as fibroblast feeder layer to provide beneficial microenvironment for the differentiation and proliferation
Human Embryonic stem cell derived MCs offer an alternative – e.g. to follow mast cell differentiation and tracking at in vitro and in vivo experiments
Summary• If more than one model exist- do you distinct models yield similar results? If not, point out the discrepancies.• Criticism of the model discussed.
Also, there are 2 human MC lines: HMC-1 and LAD2
Limitations:1. cell-lines2. immature MCs3. low amount of tryptase and chymase 4. HMC-1 don’t express FceRI
Summary
• Nothing is perfect in life
• None of the model is suitable
• The choice of the model depends on the interest of your study
THANK YOU!!